Prime
Treatments
Testing and Advancements Index
The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.
FACT SHEET
Prime Treatments, Testing and Advancements Primer
PDF
Infectious Diseases: Prime Treatments, Testing and Advancements Overview
PDF
Prime Treatments, Testing and Advancements Index Methodology Guide
PDF
Prime Treatments, Testing and Advancements Factsheet
PDF
Prime Treatments, Testing and Advancements Index
VIDEO
INDEX KEY FACTS
Base Date: December 12, 2019
Total number of holdings:
62
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization
INDEX SYMBOLS
| Version | Bloomberg | Reuters | ISIN |
|---|---|---|---|
| Prime Treatments, Testing and Advancements Index GTR | PGERM | .PGERMG | DE000SL0A030 |
| Prime Treatments, Testing and Advancements Index NTR | N/A | .PGERMN | DE000SL0A022 |
| Prime Treatments, Testing and Advancements Index PR | N/A | .PGERMP | DE000SL0A014 |
INDEX COMPOSITION
| Component Name | Ticker | Weight |
|---|---|---|
| BIONTECH SE | BNTX | 7.68% |
| QUIDEL CORP | QDEL | 6.47% |
| MODERNA INC | MRNA | 6.46% |
| BIO-RAD LABORATORIES INC | BIO | 6.42% |
| QUEST DIAGNOSTICS INC | DGX | 6.09% |
| LABORATORY CRP OF AMER HLDGS | LH | 6.06% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 4.32% |
| VIR BIOTECHNOLOGY INC | VIR | 4.08% |
| ZAI LAB LTD | ZLAB | 4.07% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | 3.73% |
| EMERGENT BIOSOLUTIONS INC | EBS | 3.34% |
| CUREVAC BV | CVAC | 3.27% |
| NOVAVAX INC | NVAX | 3.19% |
| I-MAB | IMAB | 2.53% |
| OPKO HEALTH INC | OPK | 2.50% |
| VAXCYTE INC | PCVX | 2.02% |
| INOVIO PHARMACEUTICALS INC | INO | 1.75% |
| DICERNA PHARMACEUTICALS INC | DRNA | 1.66% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 1.40% |
| VBI VACCINES INC | VBIV | 1.15% |
| ORASURE TECHNOLOGIES INC | OSUR | 1.13% |
| LUMINEX CORP | LMNX | 1.08% |
| TRANSLATE BIO INC | TBIO | 1.01% |
| ENANTA PHARMACEUTICALS INC | ENTA | 0.93% |
| NANTKWEST INC | NK | 0.86% |
| MERIDIAN BIOSCIENCE INC | VIVO | 0.78% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 0.72% |
| ALEXION PHARMACEUTICALS INC | ALXN | 0.71% |
| ABBOTT LABORATORIES | ABT | 0.66% |
| BRISTOL-MYERS SQUIBB CO | BMY | 0.66% |
| REGENERON PHARMACEUTICALS | REGN | 0.65% |
| PFIZER INC | PFE | 0.65% |
| ABBVIE INC | ABBV | 0.62% |
| ASTRAZENECA PLC-SPONS ADR | AZN | 0.62% |
| JOHNSON & JOHNSON | JNJ | 0.61% |
| GILEAD SCIENCES INC | GILD | 0.60% |
| ELI LILLY & CO | LLY | 0.59% |
| MERCK & CO. INC. | MRK | 0.59% |
| SANOFI-ADR | SNY | 0.59% |
| VAXART INC | VXRT | 0.57% |
| GLAXOSMITHKLINE PLC-SPON ADR | GSK | 0.57% |
| TAKEDA PHARM-ADR | TAK | 0.56% |
| SIGA TECHNOLOGIES INC | SIGA | 0.53% |
| XBIOTECH INC | XBIT | 0.53% |
| ASSEMBLY BIOSCIENCES INC | ASMB | 0.51% |
| CEL-SCI CORP | CVM | 0.49% |
| DYNAVAX TECHNOLOGIES CORP | DVAX | 0.43% |
| CO-DIAGNOSTICS INC | CODX | 0.40% |
| ATHERSYS INC | ATHX | 0.37% |
| CUE BIOPHARMA INC | CUE | 0.35% |
| IBIO INC | IBIO | 0.32% |
| OXFORD IMMUNOTEC GLOBAL PLC | OXFD | 0.31% |
| HOOKIPA PHARMA INC | HOOK | 0.26% |
| ARBUTUS BIOPHARMA CORP | ABUS | 0.24% |
| PARATEK PHARMACEUTICALS INC | PRTK | 0.23% |
| IMV INC | IMV | 0.22% |
| CHIMERIX INC | CMRX | 0.18% |
| CONTRAFECT CORP | CFRX | 0.17% |
| CORMEDIX INC | CRMD | 0.17% |
| ENOCHIAN BIOSCIENCES INC | ENOB | 0.15% |
| PHASEBIO PHARMACEUTICALS INC | PHAS | 0.09% |
| ENZO BIOCHEM INC | ENZ | 0.09% |